Amundi
NVO

Amundi’s Novo Nordisk NVO Stock Holding History

Amundi’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
+6,000
New +$258K ﹤0.01% 1855
2025
Q2 		– Sell
-4,938,507
Closed -$332M – 2010
2025
Q1 		$332M Buy
4,938,507
+1,627,051
+49% +$134M 0.12% 175
2024
Q4 		$284M Buy
3,311,456
+692,567
+26% +$74.9M 0.1% 200
2024
Q3 		$307M Buy
2,618,889
+280,325
+12% +$37.4M 0.11% 182
2024
Q2 		$325M Buy
2,338,564
+175,951
+8% +$23.3M 0.12% 163
2024
Q1 		$266M Buy
2,162,613
+671,375
+45% +$79.9M 0.11% 188
2023
Q4 		$159M Buy
1,491,238
+1,359,388
+1,031% +$134M 0.07% 289
2023
Q3 		$13.5M Sell
131,850
-48,878
-27% -$4.31M 0.01% 779
2023
Q2 		$14.4M Sell
180,728
-141,680
-44% -$11.6M 0.01% 768
2023
Q1 		$25.5M Sell
322,408
-311,190
-49% -$22.1M 0.01% 664
2022
Q4 		$42M Sell
633,598
-5,242
-0.8% -$307K 0.02% 539
2022
Q3 		$33.9M Sell
638,840
-56,132
-8% -$3.01M 0.02% 584
2022
Q2 		$38M Sell
694,972
-122,538
-15% -$6.8M 0.03% 499
2022
Q1 		$49.8M Buy
817,510
+2,668
+0.3% +$137K 0.03% 467
2021
Q4 		$40.6M Buy
814,842
+9,202
+1% +$499K 0.03% 521
2021
Q3 		$38.7M Sell
805,640
-273,052
-25% -$13.2M 0.03% 516
2021
Q2 		$45.2M Buy
+1,078,692
New +$41.8M 0.03% 465

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Amundi's NVO Position: Q2 2026 in Review

Amundi opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,000 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #1855 among its holdings. This is a return to the name: Amundi previously reported a position in NVO as recently as Q1 2025.

Amundi first reported a position in NVO in Q2 2021 and has held it in 17 quarters since. The position peaked at $332M in Q1 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Amundi held 6,000 shares of Novo Nordisk worth $288K as of Q2 2026.
  • Novo Nordisk was a new Amundi position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1855 holding.
  • Amundi first reported a position in Novo Nordisk in Q2 2021 and has held it in 17 quarters since.
  • Amundi's Novo Nordisk position peaked at $332M in Q1 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.